Search results
J&J (JNJ) Seeks Approval for Bladder Cancer Drug in Europe
Zacks via Yahoo Finance· 8 months agoJ&J's (JNJ) erdafitinib is already marketed as Balversa in the United States for FGFR-altered...
Oppenheimer Says These 2 Stocks Have Double-Digit Gains in Sight
TipRanks via Yahoo Finance· 1 year ago2023 is well underway now, and the key story is the sudden change in sentiment on the financial...
Incyte's (INCY) Pemazyre Gets Approval to Treat MLNs in Japan
Zacks via Yahoo Finance· 1 year agoIncyte INCY announced that it has received approval for treating patients with myeloid or lymphoid...
Personalised drug therapy hope for bile duct cancer patients
Press Association News via AOL· 1 year agoA drug treatment for bile duct cancer patients with a rare mutation has been shown to improve...
BridgeBio Soars 52% And Breaks Out After Smashing Expectations In A Dwarfism Study
Investor's Business Daily· 1 year agoBridgeBio Pharma smashed Wall Street's expectations in a study of children with dwarfism, leading...
Incyte (INCY) Gets FDA Nod for Label Expansion of Pemazyre
Zacks via Yahoo Finance· 2 years agoIncyte (INCY) obtains FDA approval for Pemazyre for a second indication - the treatment of adults...
These 2 “Strong Buy” Penny Stocks Could Surge 200% (or More), Says Wedbush
TipRanks via Yahoo Finance· 11 months agoInvestors are constantly looking for stocks that will yield massive returns. That being said,...
Incyte (INCY) to Report Q4 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 1 year agoIncyte Corporation INCY is scheduled to release its fourth-quarter and full-year 2022 results on Feb...
Man given 1 year to live survives brain cancer
ABC News via Yahoo News· 1 year agoDiane Pathieu said she was told her husband Nick Adamski only had a year to live. Pathieu, who is a reporter with Chicago ABC affiliate WLS, shared her...
Pharma Stock Roundup: J&J's New '23 View After Kenvue Separation, Regulatory Updates
Zacks via Yahoo Finance· 8 months agoJ&J (JNJ) updates its financial guidance for 2023 after the final separation of Kenvue. Pfizer,...
